Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $180
Molina Healthcare, Inc.
Molina Healthcare, Inc. MOH | 0.00 |
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:
MOH) with a Underweight and lowers the price target from $184 to $180.
